최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Biochemical and biophysical research communications, v.522 no.3, 2020년, pp.669 - 675
Lee, Woonghee (Department of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, School of Medicine, Kyungpook National University) , Sarkar, Swarbhanu (Department of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, School of Medicine, Kyungpook National University) , Ahn, Heesu (Department of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, School of Medicine, Kyungpook National University) , Kim, Jung Young (Division of Applied RI, Korea Institute of Radiological and Medical Sciences) , Lee, Yong Jin (Division of Applied RI, Korea Institute of Radiological and Medical Sciences) , Chang, Yongmin (Department of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, School of Medicine, Kyungpook National University) , Yoo, Jeongsoo (Department of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, School of Me)
Abstract Boron neutron capture therapy (BNCT) is a binary radiotherapy based on nuclear reactions that occur when boron-10 is irradiated with neutrons, which result in the ejection of high-energy alpha particles. Successful BNCT requires the efficient delivery of a boron-containing compound to effe...
Angew. Chem. Int. Ed. Hawthorne 32 950 1993 10.1002/anie.199309501 The role of chemistry in the development of boron neutron-capture therapy of cancer
Cancer Commun. Barth 38 35 2018 10.1186/s40880-018-0299-7 Boron delivery agents for neutron capture therapy of cancer
Appl. Radiat. Isot. Barth 67 S3 2009 10.1016/j.apradiso.2009.03.102 Boron neutron capture therapy at the crossroads: challenges and opportunities
Radiat. Oncol. Barth 7 146 2012 10.1186/1748-717X-7-146 Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer
J. Med. Chem. Altieri 52 7829 2009 10.1021/jm900763b Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy
P. Natl. Acad. Sci. USA. Feakes 92 1367 1995 10.1073/pnas.92.5.1367 Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes
P Natl Acad Sci USA Kueffer 110 6512 2013 10.1073/pnas.1303437110 Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes
P Natl Acad Sci USA Shelly 89 9039 1992 10.1073/pnas.89.19.9039 Model studies directed toward the boron neutron-capture therapy of cancer - boron delivery to murine tumors with liposomes
Biomaterials Gao 104 201 2016 10.1016/j.biomaterials.2016.06.046 Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects
Chem. Commun. Tachikawa 50 12325 2014 10.1039/C4CC04344H Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy
Transl. Oncol. Maitz 10 686 2017 10.1016/j.tranon.2017.05.003 Validation and comparison of the therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes in multiple murine tumor models
Bioconjug. Chem. Koganei 24 124 2013 10.1021/bc300527n Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy of cancers
Chem. Rev. Scholz 111 7035 2011 10.1021/cr200038x Carbaboranes as pharmacophores: properties, synthesis, and application strategies
Dalton Trans. Armstrong 4240 2007 10.1039/b709843j The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy
Adv. Drug Deliv. Rev. Fang 63 136 2011 10.1016/j.addr.2010.04.009 The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Adv. Drug Deliv. Rev. Maruyama 63 161 2011 10.1016/j.addr.2010.09.003 Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
Acc. Chem. Res. Al-Jamal 44 1094 2011 10.1021/ar200105p Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine
Colloids Surf., B Eloy 123 345 2014 10.1016/j.colsurfb.2014.09.029 Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery
Contrast Media Mol. Jung I 3727109 2018 Image-guided neutron capture therapy using the Gd-DO3A-BTA complex as a new combinatorial treatment approach
ACS Med. Chem. Lett. Kim 5 390 2014 10.1021/ml400513g Vivid tumor imaging utilizing liposome-carried bimodal radiotracer
Proc. Natl. Acad. Sci. U. S. A. Feakes 91 3029 1994 10.1073/pnas.91.8.3029 Na3[B20H17NH3]: synthesis and liposomal delivery to murine tumors
Int. J. Pharm. Xu 423 410 2012 10.1016/j.ijpharm.2011.12.019 Predicting hydrophilic drug encapsulation inside unilamellar liposomes
Compos. Sci. Technol. Zhang 150 16 2017 10.1016/j.compscitech.2017.06.007 Enhancing the neutron shielding ability of polyethylene composites with an alternating multi-layered structure
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.